drugset / Trial / NCT00003677
Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of dolastatin 10 in treating patients who have metastatic pancreatic cancer.
Timeline
- Start
- 1999-02-01
- Primary completion
- 2002-01-16
- Completion
- 2002-01-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | dolastatin 10 | Peptide | — | Intravenous |